These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Evaluation of immediate results in the treatment of lymphogranulomatosis with dopan and degranol]. RAEVSKII IG Vopr Onkol; 1962; 8(4)():3-11. PubMed ID: 14489811 [No Abstract] [Full Text] [Related]
5. [TREATMENT OF LYMPHOGRANULOMATOSIS WITH DOPAN AND DEGRANOL]. KOLESNIKOV IuP Sov Med; 1965 Jan; 28():116-9. PubMed ID: 14307884 [No Abstract] [Full Text] [Related]
6. [Change in the form of lymphogranulomatosis under cytostatic therapy]. KRUECKEMEYER K; LOOCK KH Munch Med Wochenschr; 1962 Sep; 104():1726-9. PubMed ID: 13927074 [No Abstract] [Full Text] [Related]
7. [EXPERIMENTAL REGIONAL PERFUSION OF THE EXTREMITIES WITH CYTOSTATICS]. HUSVETI S; BESZNYAK I; KUDASZ J Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1963 Nov; 304():722-5. PubMed ID: 14120191 [No Abstract] [Full Text] [Related]
8. [DATA ON THE MECHANISM OF ACTION OF DEGRANOL]. KOEROES Z; HARTAI F; MATE WOJCINSKA U; SELLEI C Magy Onkol; 1964 Mar; 8():18-23. PubMed ID: 14141978 [No Abstract] [Full Text] [Related]
9. [STUDIES ON THE SUCCINOTRANSHYDROGENASE-INHIBITING CAPACITY OF CYTOSTATICS]. DOMBRADI G Kiserl Orvostud; 1963 Oct; 15():503-7. PubMed ID: 14092925 [No Abstract] [Full Text] [Related]
10. [Experiences with new cytostatic drugs in leukosis and lymphogranulomatosis and the delimitation of their effects from roentgen therapy]. SCHULTE G; LINGS H Strahlentherapie; 1953; 90(2):301-6. PubMed ID: 13077011 [No Abstract] [Full Text] [Related]
11. [THE REDUCTION OF RADIOPHOSPHORUS 32 INCORPORATION INTO CANCER CELLS BY NONTOXIC DOSES OF CYTOSTATIC SUBSTANCES]. KREPSZ I; PUPP A; GYERGYAY F Radiobiol Radiother (Berl); 1963; 4():479-82. PubMed ID: 14120270 [No Abstract] [Full Text] [Related]
12. [Use of embichin in lymphogranulomatosis in children]. RUDCHENKO NB Pediatriia; 1958 Sep; 23(9):58-61. PubMed ID: 13613900 [No Abstract] [Full Text] [Related]
13. [Critical observations on the treatment of lymphogranulomatosis with nitrogen mustards]. PINKER H; BRAUN H Arztl Wochensch; 1950 Apr; 5(13-14):207-10. PubMed ID: 15419094 [No Abstract] [Full Text] [Related]
14. [Nitrogen mustard therapy of lymphogranulomatosis]. MOESER H Med Klin; 1950 Sep; 45(37):1185-6. PubMed ID: 14785530 [No Abstract] [Full Text] [Related]
15. [Cytostasis due to triethylene melamine (TEM) in lymphogranulomatosis and chronic leukemia]. NEUMANN C Klin Wochenschr; 1952 Dec; 30(47-48):1105-8. PubMed ID: 13023980 [No Abstract] [Full Text] [Related]
16. [The action of vaccinia and herpes viruses and of the cytostatic drugs, degranol and TEM, on several experimental pulmonary tumors]. COSTACHEL O; ILIE B Stud Cercet Inframicrobiol; 1961; 12():317-23. PubMed ID: 13881598 [No Abstract] [Full Text] [Related]
17. A SIMPLE QUANTITATIVE METHOD FOR THE INVESTIGATION OF THE INHIBITING ACTION OF CYTOSTATICS ON SUCCINATE DEHYDROGENASE. DOMBRADI GA Enzymologia; 1964 Feb; 26():321-8. PubMed ID: 14117127 [No Abstract] [Full Text] [Related]
18. [Roentgen resistant lymphogranulomatosis treated with trichlorotriethylamine hydrochloride, with special reference to following modifications in the hemopoietic system]. TEWES H Med Monatsschr; 1950 Jul; 4(7):534-7. PubMed ID: 15438635 [No Abstract] [Full Text] [Related]
19. [Efficacy and limitations of karyoklastic therapy of leukosis, lymphogranulomatosis, and malignant tumors in childhood]. WEICKER H Kinderarztl Prax; 1950; 18():143-50. PubMed ID: 14785133 [No Abstract] [Full Text] [Related]
20. [ANEMIC AND LATENT HEMOLYTIC SYNDROME IN 2 CASES OF SPLENOMEGLAIC LYMPHOGRANULOMATOSIS]. MILOSAVLJEVIC A; GUZINA D; BUGARSKI M; PANTELIC M Srp Arh Celok Lek; 1964 Oct; 92():1003-8. PubMed ID: 14294162 [No Abstract] [Full Text] [Related] [Next] [New Search]